T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Bloomin' Brands
BLMN
$975M
| $98.2M | 0.02% |
3,965,386
-31,290
| -0.8% | -$658K |
|
627
Worthington Enterprises
WOR
$2.78B
| $98M | 0.02% |
5,281,887
+177,820
| +3% | +$3.94M |
|
|
CMRX
628
DELISTED
Chimerix, Inc.
CMRX
| $97.3M | 0.02% |
2,417,262
-23,255
| -1% | -$788K |
|
629
J.M. Smucker
SJM
$12.7B
| $97.1M | 0.02% |
961,838
+697,024
| +263% | +$70.6M |
|
630
DuPont de Nemours
DD
$19.5B
| $97.1M | 0.02% |
840,442
-242,603
| -22% | -$29.6M |
|
|
RWT
631
Redwood Trust
RWT
$592M
| $96.9M | 0.02% |
4,919,525
+560
| +0% | +$10.5K |
|
632
Bankunited
BKU
$3.38B
| $96.6M | 0.02% |
3,335,210
+197,500
| +6% | +$5.83M |
|
633
NOV
NOV
$7.45B
| $96.4M | 0.02% |
1,470,374
-1,346,565
| -48% | -$93.8M |
|
|
CAVM
634
DELISTED
Cavium, Inc.
CAVM
| $95.4M | 0.02% |
1,542,821
-278,619
| -15% | -$14.7M |
|
|
LHO
635
DELISTED
LaSalle Hotel Properties
LHO
| $94.8M | 0.02% |
2,342,517
-127,053
| -5% | -$4.88M |
|
|
CBST
636
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $94.6M | 0.02% |
939,425
-1,489,859
| -61% | -$116M |
|
637
Descartes Systems
DSGX
$6.65B
| $94.6M | 0.02% |
6,375,835
+39,940
| +0.6% | +$577K |
|
|
TSRO
638
DELISTED
TESARO, Inc.
TSRO
| $94.1M | 0.02% |
2,530,539
+84,400
| +3% | +$2.6M |
|
639
Jack in the Box
JACK
$358M
| $93.8M | 0.02% |
1,172,800
-561,990
| -32% | -$40.9M |
|
640
VF Corp
VFC
$5.73B
| $93.5M | 0.02% |
1,326,185
+429,475
| +48% | +$28.4M |
|
641
Littelfuse
LFUS
$11.7B
| $93.5M | 0.02% |
967,180
+5,200
| +0.5% | +$483K |
|
|
CRAY
642
DELISTED
Cray, Inc.
CRAY
| $93.2M | 0.02% |
2,703,207
+26,010
| +1% | +$826K |
|
643
Freeport-McMoran
FCX
$96.9B
| $92.9M | 0.02% |
3,976,731
-193,943
| -5% | -$5.35M |
|
644
Kirby Corp
KEX
$7.18B
| $92.5M | 0.02% |
1,145,662
-373,961
| -25% | -$37M |
|
|
AEC
645
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
| $92.2M | 0.02% |
3,970,310
+1,131,964
| +40% | +$23.4M |
|
646
Progress Software
PRGS
$1.79B
| $92M | 0.02% |
3,403,890
-1,168,380
| -26% | -$30.3M |
|
647
Brinker International
EAT
$10.5B
| $91.3M | 0.02% |
1,555,594
-91,570
| -6% | -$4.99M |
|
|
CAM
648
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $91.2M | 0.02% |
1,826,277
-105,855
| -5% | -$5.86M |
|
|
MNK
649
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $90.7M | 0.02% |
915,610
-545,417
| -37% | -$50.2M |
|
650
CMS Energy
CMS
$22B
| $90.2M | 0.02% |
2,596,154
+301,250
| +13% | +$9.84M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.